It is rebuilding muscle, replenishing iron stores, and supporting a brain that is forming entirely new neural pathways around caregiving
Novo Nordisk's strategy to in-licence its molecule for marketing to drugmakers Emcure and Abbott will play a key role in expanding its reach beyond the metros to tier-1 and tier-2 cities, said experts
HS is a debilitating disease that often requires repeated surgeries and hospitalizations, yet current treatment options remain limited, with many patients not responding adequately to biologics or antibiotics, Jared Jagdeo, MD, MS, associate professor of dermatology and molecular cell biology and director of the Laser Aesthetic and Body Institute, the Center for Photomedicine and the Skin of Color Center at SUNY Downstate Health Sciences University, told Healio
[5] One honest caveat, though: theres no direct head-to-head Phase 3 trial yet, so all of this is stitched together from separate trials